Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Acq. announced
Director departure
Appointed director
|
|
Medicine Man Technologies, Inc. (MDCL)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/10/2023 |
4
| Wahdan Salim Husan (Director) has filed a Form 4 on Medicine Man Technologies, Inc.|
Txns:
| Granted 10,892 shares
@ $0 |
|
| 10/06/2023 |
4
| Dye Justin (10% Owner) has filed a Form 4 on Medicine Man Technologies, Inc.|
Txns:
| Granted 130,801 shares
@ $0 |
|
| 10/05/2023 |
4
| Stewart Brad (Director) has filed a Form 4 on Medicine Man Technologies, Inc.|
Txns:
| Granted 13,825 shares
@ $0
Granted 34,870 shares
@ $0 |
|
| 10/05/2023 |
4
| Montalbano Paul Joseph (Director) has filed a Form 4 on Medicine Man Technologies, Inc.|
Txns:
| Granted 33,228 shares
@ $0 |
|
| 10/05/2023 |
4
| Mukharji Pratap Chandra (Director) has filed a Form 4 on Medicine Man Technologies, Inc.|
Txns:
| Granted 33,228 shares
@ $0 |
|
| 10/05/2023 |
4
| Rubin Marc R (10% Owner) has filed a Form 4 on Medicine Man Technologies, Inc.|
Txns:
| Granted 33,228 shares
@ $0 |
|
| 10/05/2023 |
4
| Berger Jonathan W (Director) has filed a Form 4 on Medicine Man Technologies, Inc.|
Txns:
| Granted 12,136 shares
@ $0
Granted 40,900 shares
@ $0 |
|
| 10/05/2023 |
4
| Garwood Jeff (Director) has filed a Form 4 on Medicine Man Technologies, Inc.|
Txns:
| Bought 22,152 shares
@ $0 |
|
| 10/05/2023 |
4
| Cozad Jeffrey Alley (10% Owner) has filed a Form 4 on Medicine Man Technologies, Inc.|
Txns:
| Granted 34,253 shares
@ $0 |
|
| 08/17/2023 |
8-K/A
| Financial Statements and Exhibits Interactive Data|
Docs:
|
"Unaudited Pro Forma Condensed Combined Statement of Operations for the year ended December 31, 2022",
"EVEREST APOTHECARY, INC. FINANCIAL STATEMENT JUNE 1, 2023 EVEREST APOTHECARY, INC.",
"Medicine Man Technologies, Inc. Unaudited Pro Forma Condensed Combined Financial Information The unaudited pro forma condensed combined statements of operations for the six months ended June 30, 2023 and for the year ended December 31, 2022 combine the financial statements of Medicine Man Technologies, Inc. and Everest Apothecary, Inc. giving effect to the transaction described in the Agreement, as if they had occurred on January 1, 2022 in respect of the unaudited pro forma condensed combined statements of operations. The unaudited pro forma condensed combined financial information should be read in conjunction with: · Medicine Man’ s audited consolidated financial statements and accompanying notes as of and for the year ended December 31, 2022, as contained in the Form 10-K filed ..." |
|
| 08/10/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/09/2023 |
8-K
| Quarterly results |
| 08/08/2023 |
8-K/A
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 06/07/2023 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financia...|
Docs:
|
"AMENDMENT TO ASSET PURCHASE AGREEMENT",
"CALL OPTION AGREEMENT",
"PROMISSORY NOTE $17,500,000 June 1, 2023 For value received, Evergreen Holdco, LLC, a New Mexico limited liability company, and Medicine Man Technologies, Inc., a Nevada corporation , jointly and severally promise to pay to the order of Sucellus, LLC, a New Mexico limited liability company , the aggregate principal amount of $17,500,000 , together with all accrued but unpaid interest thereon, in accordance with and subject to the provisions of this Promissory Note . This Seller Note is being issued as a portion of the Purchase Price, pursuant to that certain Asset Purchase Agreement, dated as of April 21, 2023, 2023 , by and among Payor, Holder and each other signatory thereto. Any terms not otherwise defined herein shall have the meanings ascribed to them in the Purchase Agreement. 1. Int...",
"SCHWAZZE COMPLETES ACQUISITION TO MANAGE ASSETS OF NEW MEXICO CANNABIS OPERATOR, EVEREST APOTHECARY, INC. Acquisition Increases Schwazze’ s New Mexico Retail Store Count to 32 and Provides Expanded Coverage Throughout State" |
|
| 05/31/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"AGREEMENT THIS AGREEMENT is made as of this 27th day of May 2023 by and between Justin Dye, an individual , and MEDICINE MAN TECHNOLOGIES, INC., a corporation duly organized under the laws of the state of Nevada and having its principal place of business at 4880 Havana Street, Suite 201 South, Denver, Colorado 80239 and its affiliates and subsidiaries . The existence of this Agreement will be announced publicly by MMT in MMT’ s sole discretion. RECITALS A. Dye is currently employed by the Company as its Chief Executive Officer and Executive Chairman pursuant to that certain employment agreement dated as of December 5, 2019, by and between the Company and Dye, as amended by the First Amendment to Justin Dye Employment Agreement, dated June 14, 2021 ; and B. Dye and the Company have agreed t...",
"AMENDED AND RESTATED EMPLOYMENT AGREEMENT THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT is made and entered into this 24th day of May 2023 by and between Nirup Krishnamurthy, an individual , and MEDICINE MAN TECHNOLOGIES, INC. , a corporation duly organized under the laws of the state of Nevada and having its principal place of business at 4880 Havana Street, Suite 201 South, Denver, Colorado 80239 and its affiliates and subsidiaries . Executive and Company may hereinafter be referred to jointly as the “Parties.” W I T N E S S E T H: WHEREAS, Executive and Company previously entered into an employment agreement on March 1, 2020 , as amended by the First Amendment to Employment Agreement dated March 1, 2020 and the Second Amendment to Employment Agreement dated October 5, 2022 . Together, ...",
"MULTI-STATE CANNABIS OPERATOR, SCHWAZZE, PROMOTES NIRUP KRISHNAMURTHY TO CHIEF EXECUTIVE OFFICER DENVER, CO – May 31, 2023 – Medicine Man Technologies, Inc., operating as Schwazze, , is pleased to announce the promotion of its President, Nirup Krishnamurthy, to the role of Chief Executive Officer. Justin Dye – the company’ s former Chief Executive Officer and Executive Chairman – will continue to lead the Board of Directors as its non-executive Chairman. This appointment is part of a succession planning process that began nearly a year ago when Justin Dye, the CEO and Executive Chairman, informed the Board of his desire to transition into a Chairman role. Nirup was handpicked by Justin as his successor with the full support of the Company’ s Board and was promoted to President of Schwazze..." |
|
| 05/16/2023 |
8-K
| Unregistered Sales of Equity Securities, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits ... |
| 05/10/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/10/2023 |
8-K
| Quarterly results |
| 05/05/2023 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 04/27/2023 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 04/26/2023 |
8-K
| Quarterly results |
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2023 |
8-K
| Quarterly results |
| 04/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/03/2023 |
8-K/A
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/29/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/29/2023 |
8-K
| Quarterly results |
|
|
|